Pharmaceutical

Morning Rounds: Americans put faith in nurses as overall confidence in health care ebbs

Morning Rounds: Americans put faith in nurses as overal...

Dec 21, 2023

Understand how science, health policy, and medicine shape the world everyday. Si...

Inhaled vaccines could stop Covid infections, monkey studies show

Inhaled vaccines could stop Covid infections, monkey st...

Dec 21, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Curevac loses key patent in battle with BioNTech; Abernethy to step down as Verily CMO

STAT+: Pharmalittle: Curevac loses key patent in battle...

Dec 21, 2023

A German court invalidated a patent at the center of a CureVac lawsuit against B...

STAT+: In another blow, Argenx antibody therapy fails in trial for skin blistering condition

STAT+: In another blow, Argenx antibody therapy fails i...

Dec 21, 2023

Argenx said Wednesday that its closely watched therapy failed to outperform plac...

STAT+: 3 trends to watch in biotech in 2024

STAT+: 3 trends to watch in biotech in 2024

Dec 21, 2023

After two years of steady decline in biotech, industry optimists might be onto s...

Opinion: The U.S. must raise federal alcohol taxes to address the alarming rise in alcohol use

Opinion: The U.S. must raise federal alcohol taxes to a...

Dec 21, 2023

The U.S. must raise federal alcohol taxes to address the alarming rise in alcoho...

MABS-139 by Manhattan Biosolutions for Solid Tumor: Lik...

Dec 20, 2023

MABS-139 is under clinical development by Manhattan Biosolutions and currently i...

FLU-SV-mRNA by Curevac for Influenza A Virus, H1N1 Subt...

Dec 20, 2023

FLU-SV-mRNA is under clinical development by Curevac and currently in Phase I fo...

ND-10 ER by Theialife Sciences for Myopia: Likelihood o...

Dec 20, 2023

ND-10 ER is under clinical development by Theialife Sciences and currently in Ph...

Meloxicam fast acting by Viatris for Post-Operative Pai...

Dec 20, 2023

Meloxicam fast acting is under clinical development by Viatris and currently in ...

NNC-05600004 by Novo Nordisk for Liver Diseases: Likeli...

Dec 20, 2023

NNC-05600004 is under clinical development by Novo Nordisk and currently in Phas...

GUB-014295 by Gubra for Obesity: Likelihood of Approval

Dec 20, 2023

GUB-014295 is under clinical development by Gubra and currently in Phase I for O...

UI-059 by Korea United Pharm for Reflux Esophagitis (Ga...

Dec 20, 2023

UI-059 is under clinical development by Korea United Pharm and currently in Phas...

GLB-001 by GluBio Therapeutics for Refractory Acute Mye...

Dec 20, 2023

GLB-001 is under clinical development by GluBio Therapeutics and currently in Ph...

GLB-001 by GluBio Therapeutics for Myelodysplastic Synd...

Dec 20, 2023

GLB-001 is under clinical development by GluBio Therapeutics and currently in Ph...

GLB-001 by GluBio Therapeutics for Relapsed Acute Myelo...

Dec 20, 2023

GLB-001 is under clinical development by GluBio Therapeutics and currently in Ph...